{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Twelve asthmatic patients ( FEV1 , 81 + / - 4 % predicted ) , requiring only occasional inhaled beta - agonists as their sole therapy , were given a 14 - day treatment with high dose inhaled salbutamol ( HDS ) , 4 , 000 micrograms daily , low dose inhaled salbutamol ( LDS ) , 800 micrograms daily , or placebo ( PI ) by metered - dose inhaler in a double - blind , randomized crossover design .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| asthmatic patients |\n\nExplanation:\n\nThe word or phrase that represents a disease in the given paragraph is \"asthmatic patients\". I have ensured that the entity is presented precisely in the same words as in the original paragraph."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| asthmatic patients |\n\nExplanation:\n\nThe only word or phrase that represents a disease in the given paragraph is \"asthmatic patients\". I have ensured that the entity is presented precisely in the same words as in the original paragraph. The other entities like \"HDS\", \"LDS\", and \"PI\" are not diseases, but treatments or placebos."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Twelve asthmatic patients ( FEV1 , 81 + / - 4 % predicted ) , requiring only occasional inhaled beta - agonists as their sole therapy , were given a 14 - day treatment with high dose inhaled salbutamol ( HDS ) , 4 , 000 micrograms daily , low dose inhaled salbutamol ( LDS ) , 800 micrograms daily , or placebo ( PI ) by metered - dose inhaler in a double - blind , randomized crossover design .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| HDS (High Dose Inhaled Salbutamol) |\n| LDS (Low Dose Inhaled Salbutamol) |\n| salbutamol |\n\nThe chemical entities in the paragraph are \"High Dose Inhaled Salbutamol (HDS)\", \"Low Dose Inhaled Salbutamol (LDS)\", and \"salbutamol\". These are the active substances being administered to the patients in the study."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| salbutamol |\n\nThe only valid chemical entity in the paragraph is \"salbutamol\", which is a medication used in the treatment of asthma. The other entities, \"High Dose Inhaled Salbutamol (HDS)\" and \"Low Dose Inhaled Salbutamol (LDS)\", are forms of the medication, but they are not chemical substances themselves."}
  ]
}